Indicated for: inflammatory bowel disease
Route of administration: oral
Substance: mesalazine (anti-inflammatory agent)
ATC: A07EC02 (Alimentary tract and metabolism | Intestinal antiinflammatory agents | Aminosalicylic acid and similar agents)
Mesalazine is a medication used to treat inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease. It is effective for both inducing remission and maintaining it, helping to reduce inflammation in the intestinal lining.
Mesalazine works locally in the intestine by inhibiting the production of inflammatory substances, such as prostaglandins and leukotrienes. It is available in the form of tablets, suppositories, or enemas, depending on the location of the inflammation in the digestive tract.
Side effects are usually mild and may include nausea, abdominal pain, diarrhea, headache, or skin rashes. In rare cases, more serious reactions can occur, such as kidney or liver dysfunction or severe allergic reactions. It is important to take mesalazine as prescribed by a doctor, with regular blood and urine tests to monitor for potential complications.
Price
Copayment
Patient
192.67 RON
114.39 RON
78.28 RON